Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Arnaldi

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 23, 2025
The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysisGianmaria Salvio, Alessandro Ciarloni, Nairus Aboud, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomasPaola Luciani, Pietro Ferruzzi, Giorgio Arnaldi, et al.
Clinical Endocrinology|April 28, 2005
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumoursSimona Freddi, Giorgio Arnaldi, Francesca Fazioli, et al.
Plos One|May 9, 2025
Structural analysis of social behavior: Using cluster analysis to examine personality profile associated with diabetes onsetAnna Vespa, Roberta Spatuzzi, Paolo Fabbietti, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Pituitary|October 11, 2022
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2)Maria Fleseriu, Beverly M K Biller, Jérôme Bertherat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing SyndromeGuido Di Dalmazi, Henri J L M Timmers, Giorgio Arnaldi, et al.
Frontiers in Endocrinology|April 26, 2021
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 StudyRosario Pivonello, Atanaska Elenkova, Maria Fleseriu, et al.
Endocrine|March 12, 2016
The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndromeValentina Guarnotta, Marco C Amato, Rosario Pivonello, et al.
Pituitary|May 30, 2016
Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndromeMattia Barbot, Laura Trementino, Marialuisa Zilio, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|December 23, 2025
The effect of hypercortisolism treatment on dyslipidemia in Cushing syndrome: systematic review and meta-analysisGianmaria Salvio, Alessandro Ciarloni, Nairus Aboud, et al.
The Journal of Clinical Endocrinology and Metabolism|March 6, 2004
Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomasPaola Luciani, Pietro Ferruzzi, Giorgio Arnaldi, et al.
Clinical Endocrinology|April 28, 2005
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumoursSimona Freddi, Giorgio Arnaldi, Francesca Fazioli, et al.
Plos One|May 9, 2025
Structural analysis of social behavior: Using cluster analysis to examine personality profile associated with diabetes onsetAnna Vespa, Roberta Spatuzzi, Paolo Fabbietti, et al.
International Journal of Cancer|January 14, 2014
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trialsMatteo Santoni, Alessandro Conti, Francesco Massari, et al.
Pituitary|October 11, 2022
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2)Maria Fleseriu, Beverly M K Biller, Jérôme Bertherat, et al.
The Journal of Clinical Endocrinology and Metabolism|July 6, 2019
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing SyndromeGuido Di Dalmazi, Henri J L M Timmers, Giorgio Arnaldi, et al.
Frontiers in Endocrinology|April 26, 2021
Levoketoconazole in the Treatment of Patients With Cushing's Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 StudyRosario Pivonello, Atanaska Elenkova, Maria Fleseriu, et al.
Endocrine|March 12, 2016
The degree of urinary hypercortisolism is not correlated with the severity of cushing's syndromeValentina Guarnotta, Marco C Amato, Rosario Pivonello, et al.
Pituitary|May 30, 2016
Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndromeMattia Barbot, Laura Trementino, Marialuisa Zilio, et al.
Pageof 10